UCB's Global Corporate Website
Welcome to UCB in the United States


Find U.S. news and updates from UCB, a global biopharmaceutical company focused on creating value for people living with severe diseases, such as epilepsy, Parkinson’s disease, psoriasis, osteoporosis, myasthenia gravis,  rheumatoid arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis, and more. 

Spotlight Story

No results



UCB U.S. News

UCB on Growth Path for a Decade Plus

Read More

Rare Disease Day 2024: The Moment is Now to Be Patient-First to Deliver for People Living with Rare…

Read More

Harmony in Health: Partnering for Enhanced Seizure Management and Understanding

Read More

Twitter Feed

For More Information